Anavex Life Sciences Balance Sheet (2010-2025) | AVXL

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	75.86M	157.56M	152.11M	151.15M	153.34M	153.20M	149.16M	143.62M	153.47M	154.82M	151.02M	143.76M	139.39M	138.76M	132.19M	120.78M	115.77M	101.16M	102.58M	131.75M
Short-term Investments (Quarter)
Cash & Current Investments (Quarter)	75.86M	157.56M	152.11M	151.15M	153.34M	153.20M	149.16M	143.62M	153.47M	154.82M	151.02M	143.76M	139.39M	138.76M	132.19M	120.78M	115.77M	101.16M	102.58M	131.75M
Receivables - Other (Quarter)							2.90M				2.50M				2.30M	2.40M	0.50M	0.60M	0.70M	0.70M
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	0.39M	0.26M	0.37M	0.38M	0.46M	0.46M	0.35M	0.66M	0.98M	0.83M	0.65M	0.76M	1.34M	1.06M	0.93M	0.71M	0.70M	0.45M	0.43M	0.40M
Current Assets (Quarter)
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Long-Term Deferred Tax (Quarter)											7.20M				15.10M				20.70M
Other Non-Current Assets (Quarter)
Non-Current Assets (Quarter)
Assets (Quarter)	83.57M	166.42M	161.62M	156.90M	160.28M	160.22M	152.71M	148.37M	159.19M	157.81M	154.39M	148.07M	144.52M	141.53M	135.57M	124.04M	117.14M	102.43M	103.81M	132.99M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.66M	4.18M	4.74M	4.63M	2.63M	3.13M	3.83M	5.29M	6.28M	4.15M	4.32M	4.29M	3.73M	3.50M	9.63M	4.57M	7.00M	6.74M	4.25M	2.64M
Notes Payables (Quarter)
Payables (Quarter)	3.66M	4.18M	4.74M	4.63M	2.63M	3.13M	3.83M	5.29M	6.28M	4.15M	4.32M	4.29M	3.73M	3.50M	9.63M	4.57M	7.00M	6.74M	4.25M	2.64M
Accumulated Expenses (Quarter)	3.62M	4.65M	5.61M	5.45M	5.00M	5.91M	1.30M	1.25M	6.82M	5.99M	7.29M	7.29M	4.92M	7.33M	4.83M	7.73M	9.55M	3.93M	3.89M	2.93M
Other Accumulated Expenses (Quarter)			1.73M	2.20M	1.79M	2.05M	2.06M	2.50M	1.96M	2.15M	2.62M	2.09M	1.53M	2.28M	1.89M	2.52M	1.56M	2.04M
Short term Debt (Quarter)
Current Deferred Revenue (Quarter)	0.49M	0.44M	0.44M	0.44M	0.44M	0.44M	0.44M	0.92M	0.92M	0.92M	0.92M	0.92M	0.92M	0.92M	0.84M	0.83M	0.83M	0.81M
Total Current Liabilities (Quarter)	7.76M		10.80M	10.53M	8.07M	9.48M
Non-Current Liabilities
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)			0.44M				0.44M				0.92M				0.84M				0.81M	0.81M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)
Total Liabilities (Quarter)	7.76M	9.27M	10.80M	10.53M	8.07M	9.48M	10.21M	13.25M	14.02M	11.06M	12.53M	12.49M	9.56M	11.75M	15.30M	13.13M	17.38M	11.47M	8.95M	6.37M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	75.81M	157.15M	150.82M	146.37M	152.21M	150.74M	142.49M	135.12M	145.16M	146.75M	141.85M	135.57M	134.96M	129.78M	120.26M	110.92M	99.76M	90.96M	94.87M	126.62M
Shareholder's Equity (Quarter)	75.81M	157.15M	150.82M	146.37M	152.21M	150.74M	142.49M	135.12M	145.16M	146.75M	141.85M	135.57M	134.96M	129.78M	120.26M	110.92M	99.76M	90.96M	94.87M	126.62M
Liabilities and Shareholders Equity (Quarter)	83.57M	166.42M	161.62M	156.90M	160.28M	160.22M	152.71M	148.37M	159.19M	157.81M	154.39M	148.07M	144.52M	141.53M	135.57M	124.04M	117.14M	102.43M	103.81M	132.99M
Retained Earnings (Quarter)	-175.69M	-185.87M	-197.59M	-208.47M	-218.91M	-231.27M	-245.56M	-258.54M	-271.64M	-282.92M	-293.07M	-301.69M	-312.24M	-324.45M	-336.07M	-348.18M	-359.38M	-372.62M	-382.45M	-388.13M
Treasury Shares (Quarter)	0.50M	0.21M	4.01M	0.16M	0.16M	0.16M	0.16M		2.08M	1.05M	3.27M				2.45M

Research Tools

Anavex Life Sciences Balance Sheet (2010-2025) | AVXL

Create an account

Sign In

Reset Password